Tumor Heterogeneity
We study the diversity of cancer cells within tumors to understand how cellular states, spatial organization, and transcriptional programs influence disease progression, metastasis, and therapeutic response.
Unraveling the genomic complexity of cancer through computational biology.
We study the diversity of cancer cells within tumors to understand how cellular states, spatial organization, and transcriptional programs influence disease progression, metastasis, and therapeutic response.
We investigate how genetic and epigenetic alterations drive the expansion of blood cell clones, contributing to leukemia, cardiovascular disease, and age-related health outcomes.
We develop open-source computational methods and software tools to enhance and ease the interpretation of diverse data modalities, addressing topics such as error modeling and mutation calling.
Multi-omic deep sequencing to uncover clonal evolution from pre-leukemic stages. Decoding how somatic mutations drive disease.
State-of-the-art machine learning algorithms to estimate risk and detect somatic mutations with high precision.
Identifying key molecular biomarkers in healthy individuals to predict disease onset and risk classification.
Multi-omic deep sequencing to uncover clonal evolution from pre-leukemic stages. Decoding how somatic mutations drive disease.
State-of-the-art machine learning algorithms to estimate risk and detect somatic mutations with high precision.